Make your money go further for just 25p per day

Tristel looks to China for more growth

13/03/2019 · Tristel (TSTL) 

AIM UK

Tristel logo printed on purple medical type background

The value of Tristel’s medical device decontamination products are highlighted by the fact that the company has nearly fully saturated the UK market – almost every hospital in the UK uses Tristel. The company is therefore looking overseas to keep expanding. If it can achieve anywhere near the same level of success as it has done in Britain, there’s far more growth to come. Read on to find out why we’re positive the group can manage it.


Not many AIM-quoted companies have created a product which is so popular that it is used by almost every single hospital in the UK. Fewer still have become so confident that they have started using their company name as a verb. Disinfection specialist Tristel (LON: TSTL) defies the norm on both counts. Its unique chlorine dioxide formulation is the gold standard infection buster in British hospitals and its company tagline reads: “Why disinfect when you…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Tristel

Accounting shenanigans | Dividends | Contract wins

27/03/2023 · Company Insights

Results and updates covered here include news of encouraging contract wins as well as a big…


Lofty valuations | Stretched balance sheets

21/02/2023 · Company Insights

Results and updates covered in our free update here include several companies carrying lofty…


More Portfolio

Microsoft and Novo Nordisk shine for the Mega-Trends Portfolio

01/06/2023 · Cameco · Microsoft · Novo Nordisk

Data wars underpin AI Wars

Income Boosters: 9% dividend yield plus a new stock

Sign-up to our free email updates

SIGN UP